ZNF830 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.899800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.681200E-01
Normal-vs-Stage2
3.812200E-01
Normal-vs-Stage3
2.283800E-01
Normal-vs-Stage4
4.273200E-01
Stage1-vs-Stage2
6.191000E-01
Stage1-vs-Stage3
4.350000E-01
Stage1-vs-Stage4
7.178800E-01
Stage2-vs-Stage3
6.333800E-01
Stage2-vs-Stage4
4.487000E-01
Stage3-vs-Stage4
3.103800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.843400E-01
Normal-vs-AfricanAmerican
4.804200E-01
Normal-vs-Asian
2.996800E-01
Caucasian-vs-AfricanAmerican
4.807800E-01
Caucasian-vs-Asian
9.121600E-01
AfricanAmerican-vs-Asian
6.952600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.457200E-01
Normal-vs-Female
4.547000E-01
Male-vs-Female
1.736110E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.737000E-01
Normal-vs-Age(41-60Yrs)
4.676000E-01
Normal-vs-Age(61-80Yrs)
3.243900E-02
Normal-vs-Age(81-100Yrs)
3.869200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.599200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.039000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.169200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.451800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.398400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.719400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.085600E-01
Normal-vs-Daily Drinker
4.550300E-02
Normal-vs-Weekly Drinker
5.856200E-02
Normal-vs-Occasional Drinker
4.782200E-01
Normal-vs-Social Drinker
4.119200E-01
Non Drinker-vs-Daily Drinker
7.469000E-01
Non Drinker-vs-Weekly Drinker
6.870800E-01
Non Drinker-vs-Occasional Drinker
3.767800E-02
Non Drinker-vs-Social Drinker
1.801450E-01
Daily Drinker-vs-Weekly Drinker
9.254000E-01
Daily Drinker-vs-Occasional Drinker
1.208790E-01
Daily Drinker-vs-Social Drinker
3.663600E-01
Weekly Drinker-vs-Occasional Drinker
1.610640E-01
Weekly Drinker-vs-Social Drinker
4.236800E-01
Occasional Drinker-vs-Social Drinker
5.032000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.100400E-02
Normal-vs-Grade 2
1.388090E-02
Normal-vs-Grade 3
1.128490E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.339000E-01
Grade 1-vs-Grade 3
6.735600E-01
Grade 1-vs-Grade 4
7.100400E-02
Grade 2-vs-Grade 3
5.853000E-01
Grade 2-vs-Grade 4
1.388090E-02
Grade 3-vs-Grade 4
1.128490E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.390800E-01
Normal-vs-NonDiabetic
3.977800E-01
Diabetic-vs-NonDiabetic
2.471400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
8.892000E-02
Normal-vs-NoPancreatitis
3.712800E-01
Pancreatitis-vs-NoPancreatitis
9.766600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.636000E-01
Normal-vs-N1
4.732000E-02
N0-vs-N1
4.689400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.329800E-02
Normal-vs-TP53-NonMutant
7.088300E-02
TP53-Mutant-vs-TP53-NonMutant
7.997400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
